Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape


Por: Rodríguez-Agustín, A, Ayala-Suárez, R, Díez-Fuertes, F, Maleno, MJ, de Villasante, I, Merkel, A, Coiras, M, Casanova, V, Alcamí, J and Climent, N

Publicada: 4 mar 2025 Ahead of Print: 4 mar 2025
Resumen:
Introduction The HIV regulatory protein Tat enhances viral transcription and also modifies host gene expression, affecting cell functions like cell cycle and apoptosis. Residual expression of Tat protein is detected in blood and other tissues even under antiretroviral treatment. Cohort studies have indicated that, despite virologic suppression, people with HIV (PWH) are at increased risk of comorbidities linked to chronic inflammation, accelerated immune ageing, and cellular senescence, sometimes associated with abnormal genomic methylation patterns. We analysed whether Tat influences DNA methylation and subsequently impacts the transcriptional signature, contributing to inflammation and accelerated ageing.Methods We transfected Jurkat cells with full-length Tat (Tat101), Tat's first exon (Tat72), or an empty vector (TetOFF). We assessed DNA methylation modifications via the Infinium MethylationEPIC array, and we evaluated transcriptomic alterations through RNA-Seq. Methylation levels in gene promoters or body regions were correlated to their expression data, and subsequently, we performed an overrepresentation analysis to identify the biological terms containing differentially methylated and expressed genes.Results Tat101 expression caused significant hyper- and hypomethylation changes at individual CpG sites, resulting in slightly global DNA hypermethylation. Methylation changes at gene promoters and bodies resulted in altered gene expression, specifically regulating gene transcription in 5.1% of differentially expressed genes (DEGs) in Tat101- expressing cells. In contrast, Tat72 had a minimal impact on this epigenetic process. The observed differentially methylated and expressed genes were involved in inflammatory responses, lipid antigen presentation, and apoptosis.Discussion Tat expression in HIV infection may constitute a key epigenetic modelling actor that contributes to HIV pathogenesis and chronic inflammation. Clinical interventions targeting Tat blockade may reduce chronic inflammation and cellular senescence related to HIV infection comorbidities.

Filiaciones:
Rodríguez-Agustín, A:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

 Univ Barcelona UB, Barcelona, Spain

Ayala-Suárez, R:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

Díez-Fuertes, F:
 Inst Salud Carlos III ISCIII, Ctr Nacl Microbiol, AIDS Immunopathol Unit, Madrid, Spain

 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain

Maleno, MJ:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

de Villasante, I:
 Josep Carreras Leukaemia Res Inst IJC, Bioinformat Unit, Badalona, Spain

:
 Josep Carreras Leukaemia Res Inst IJC, Bioinformat Unit, Badalona, Spain

Coiras, M:
 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain

 Inst Salud Carlos III ISCIII, Ctr Nacl Microbiol, Immunopathol & Viral Reservoir Unit, Madrid, Spain

Casanova, V:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

 Univ Barcelona UB, Barcelona, Spain

Alcamí, J:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

 Univ Barcelona UB, Barcelona, Spain

 Inst Salud Carlos III ISCIII, Ctr Nacl Microbiol, AIDS Immunopathol Unit, Madrid, Spain

 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain

Climent, N:
 Inst Invest Biomed August Pi i Sunyer, Fdn Recerca Clin Barcelona, AIDS & HIV Infect Grp, Barcelona, Spain

 Univ Barcelona UB, Barcelona, Spain

 Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain
ISSN: 16643224





Frontiers in Immunology
Editorial
Frontiers Media S.A., AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 16 Número:
Páginas: 1532692-1532692
WOS Id: 001446404100001
ID de PubMed: 40103825
imagen Green Submitted, Green Published, gold

MÉTRICAS